Paperplane Therapeutics has raised $1.5 million to deal with sufferers for ache and anxiousness utilizing digital actuality, presumably making journeys to the dentist extra nice.
The Montreal, Canada-based firm speciliazes in therapeutic digital actuality options for ache and anxiousness administration in healthcare.
Glen Ventures led the spherical, with monetary assist from the Gouvernement du Québec via Investissement Québec. Strategic buyers resembling CABHI (Centre for Getting old + Mind Well being Innovation), Cedars-Sinai Mental Property Firm, Anges Québec, and Aventure Capital additionally participated.
Ache and anxiousness pose main boundaries for sufferers looking for medical care, typically resulting in delays, elevated discomfort, and extra advanced remedies. This situation is especially prevalent in dentistry, the place roughly 36% of people expertise anxiousness throughout dental visits, 12% undergo from excessive dental concern, and 22% postpone appointments till ache forces them to hunt care, leading to elevated prices and problems.
With this in thoughts, Paperplane is specializing in the North American dental market, aiming to boost affected person experiences and scientific workflows via its therapeutic digital actuality options.
Paperplane’s know-how addresses this problem by reworking dental procedures—typically perceived as painful and traumatic—into extra manageable, even nice experiences via immersive digital actuality.
Designed for sufferers of all ages, with a specific emphasis on pediatric care, Paperplane’s options assist make sufferers extra snug. Paperplane additionally streamlines scientific workflows and reduces the burden on clinicians.
“As an emergency physician, I have seen firsthand the lack of options available for managing pain and anxiety,” stated Jean-Simon Fortin, CEO of Paperplane Therapeutics, in an announcement. “Today, I’m proud to see our VR technology filling that gap, providing healthcare professionals with a more effective way to support their patients. This funding will allow us to expand our reach, enabling even more clinicians to deliver truly transformative care.”
This funding marks a major milestone in Paperplane’s progress and it’ll allow the corporate to proceed its mission of deploying digital actuality therapies within the dental sector, bettering each affected person outcomes and care supply throughout North America. Moreover, this funding will assist Paperplane’s growth into Europe via a strategic partnership with French firm HypnoVR, backed by its CE Mark certification.
Michael Goodman, founding accomplice at Glen Ventures, stated in an announcement, “Paperplane is redefining how we approach pain and anxiety management in healthcare. Their VR solutions not only enhance patient comfort but also contribute to more efficient clinical workflows. We are proud to support a company that is raising the standard of patient care while pushing the boundaries of medical innovation.”
Christopher Skeete, Quebec’s Minister for the Financial system and Minister Liable for the Combat In opposition to Racism, stated in an announcement, “Quebec’s ingenuity has the power to shape the future of our healthcare system, and Paperplane Therapeutics is a prime example. Our government is proud to support the development of solutions that improve both the quality and accessibility of patient care.”
“Paperplane Therapeutics is helping position Quebec as a leader in medical technology innovation through its virtual reality solutions,” added Bicha Ngo, CEO of Investissement Québec, in an announcement. “By rethinking the patient experience, the company demonstrates the immense potential of Quebec’s healthcare innovation ecosystem. With this investment, they now have the resources to accelerate their growth.”
